NCT05663957View on ClinicalTrials.gov

eVusheld Assessment reaL wORld Effectiveness in the VA Health System

CompletedOBSERVATIONAL
Enrollment

5,814

Participants

Timeline

Start Date

January 4, 2023

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
SARS-CoV-2, COVID-19
Interventions
DRUG

Evusheld

EVUSHELD users

Trial Locations (1)

84148-0001

Research Site, Salt Lake City

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

VA Informatics and Computing Infrastructure (VINCI)

UNKNOWN

lead

AstraZeneca

INDUSTRY